Scientists test Next-Generation shot in fight against TB
NCT ID NCT06732583
Summary
This early-stage study is testing a new experimental vaccine designed to protect against tuberculosis (TB). It will involve 36 healthy adults aged 18-49 to check if the vaccine is safe and if it triggers a protective immune response. Participants will receive either one of two dose levels of the vaccine or a placebo, and researchers will monitor for side effects and measure immune system reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rumah Sakit Islam Jakarta Cempaka Putih
RECRUITINGJakarta, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.